A 24-week Off-drug Extension Study in Sarcopenic Elderly Who Completed Treatment in the 6-month Core Study
Status:
Completed
Trial end date:
2018-12-03
Target enrollment:
Participant gender:
Summary
This extension study was a 24-week off-drug follow-up of the core CBYM338E2202 (NCT ) study
and the main objective was to determine the long-term durability of bimagrumab (BYM338)
effect after a 6-month treatment period.